Pierre Nahon (P Nahon)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 30

Top Topics

Metastatic Colorectal Cancer

Prognostic Factors

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Claudia Campani, Sandrine Imbeaud, Gabrielle Couchy, Marianne Ziol, Theo Z Hirsch, Sandra Rebouissou, Bénédicte Noblet, Pierre Nahon, Katia Hormigos, Sabrina Sidali, Olivier Seror, Valerie Taly, Nathalie Ganne Carrie, Pierre Laurent-Puig, Jessica Zucman-Rossi, Jean Charles Nault
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut (2024)
Clémentine Alitti, Agnès Rode, Hervé Trillaud, Philippe Merle, Jean-Frédéric Blanc, Lorraine Blaise, Alix Demory, Gisele Nkontchou, Véronique Grando, Marianne Ziol, Pierre Nahon, Nathalie Ganne-Carrié, Arthur Petit, Olivier Seror, Olivier Sutter, Jean Charles Nault
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver (2024)
Pierre Nahon, Maxime Ronot, Olivier Sutter, Pierre-André Natella, Samia Baloul, Isabelle Durand Zaleski, Etienne Audureau
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer. BMJ open 14 (2) (2024)
Claudia Campani, Sandrine Imbeaud, Gabrielle Couchy, Marianne Ziol, Theo Z Hirsch, Sandra Rebouissou, Bénédicte Noblet, Pierre Nahon, Katia Hormigos, Sabrina Sidali, Olivier Seror, Valerie Taly, Nathalie Ganne Carrie, Pierre Laurent-Puig, Jessica Zucman-Rossi, Jean Charles Nault
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut (2024)
François Villeret, Pierre Nahon
Atezolizumab and bevacizumab with anticoagulant or antiplatelet therapy in hepatocellular carcinoma patients: Real-world data for informed clinical decision-making. Liver international : official journal of the International Association for the Study of the Liver 44 (8) (2024)
Pierre Nahon, Maxime Ronot, Olivier Sutter, Pierre-André Natella, Samia Baloul, Isabelle Durand Zaleski, Etienne Audureau
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer. BMJ open 14 (2) (2024)
Clémentine Alitti, Agnès Rode, Hervé Trillaud, Philippe Merle, Jean-Frédéric Blanc, Lorraine Blaise, Alix Demory, Gisele Nkontchou, Véronique Grando, Marianne Ziol, Pierre Nahon, Nathalie Ganne-Carrié, Arthur Petit, Olivier Seror, Olivier Sutter, Jean Charles Nault
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver 44 (6) (2024)
Pierre Nahon, Maxime Ronot, Olivier Sutter, Pierre-André Natella, Samia Baloul, Isabelle Durand Zaleski, Etienne Audureau
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer. BMJ open 14 (2) (2024)
Pierre Nahon, Maxime Ronot, Olivier Sutter, Pierre-André Natella, Samia Baloul, Isabelle Durand Zaleski, Etienne Audureau
Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer. BMJ open 14 (2) (2024)
Carina Boros, Olivier Sutter, François Cauchy, Nathalie Ganne-Carrié, Pierre Nahon, Gisele N'kontchou, Marianne Ziol, Véronique Grando, Alix Demory, Lorraine Blaise, Fédérica Dondero, François Durand, Olivier Soubrane, Mickael Lesurtel, Alexis Laurent, Oliver Seror, Jean Charles Nault
Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence. Liver international : official journal of the International Association for the Study of the Liver 44 (6) (2024)
Carina Boros, Olivier Sutter, François Cauchy, Nathalie Ganne-Carrié, Pierre Nahon, Gisele N'kontchou, Marianne Ziol, Véronique Grando, Alix Demory, Lorraine Blaise, Fédérica Dondero, François Durand, Olivier Soubrane, Mickael Lesurtel, Alexis Laurent, Oliver Seror, Jean Charles Nault
Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence. Liver international : official journal of the International Association for the Study of the Liver (2024)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Luca Vittorio Valenti, Alessio Aghemo, Alejandro Forner, Salvatore Petta, Stefano Romeo, Pierre Nahon
Measuring the impact of the updated Steatotic liver disease nomenclature and definition. Liver international : official journal of the International Association for the Study of the Liver 43 (11) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Tae-Hwi Schwantes-An, Rebecca Darlay, Philippe Mathurin, Steven Masson, Suthat Liangpunsakul, Sebastian Mueller, Guruprasad P Aithal, Florian Eyer, Dermot Gleeson, Andrew Thompson, Beat Muellhaupt, Felix Stickel, Michael Soyka, David Goldman, Tiebing Liang, Lawrence Lumeng, Munir Pirmohamed, Bertrand Nalpas, Jean-Marc Jacquet, Romain Moirand, Pierre Nahon, Sylvie Naveau, Pascal Perney, Greg Botwin, Paul S Haber, Helmut K Seitz, Christopher P Day, Tatiana M Foroud, Ann K Daly, Heather J Cordell, John B Whitfield, Timothy R Morgan, Devanshi Seth, null null
Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors. Hepatology (Baltimore, Md.) 73 (5) (2022)
Isabelle Ollivier, Yohann Repesse, Pierre Nahon, Cendrine Chaffaut, Thông Dao, Thi Thu Nga Nguyen, Patrick Marcellin, Dominique Roulot, Victor De Ledinghen, Stanislas Pol, Dominique Guyader, Isabelle Archambeaud, Fabien Zoulim, Frédéric Oberti, Albert Tran, Jean-Pierre Bronowicki, Louis D'Alteroche, Denis Ouzan, Jean-Marie Peron, Jean-Pierre Zarski, Marc Bourliere, Dominique Larrey, Alexandre Louvet, Paul Calès, Armand Abergel, Philippe Mathurin, Ariane Mallat, Jean-Frederic Blanc, Eric Nguyen-Khac, Ghassan Riachi, Laurent Alric, Lawrence Serfaty, Teresa Antonini, Christophe Moreno, Pierre Attali, Dominique Thabut, Christophe Pilette, Jean-Didier Grange, Christine Silvain, Nicolas Carbonell, Brigitte Bernard-Chabert, Odile Goria, Claire Wartelle, Romain Moirand, Christos Christidis, Gabriel Perlemuter, Violaine Ozenne, Jean Henrion, Sophie Hillaire, Vincent Di Martino, Xavier Amiot, Angela Sutton, Nathalie Barget, Sylvie Chevret, Nathalie Ganne-Carrie, null null
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts. Liver international : official journal of the International Association for the Study of the Liver 42 (6) (2022)
Su Pin Choo, Pierre Nahon
Atezolizumab and bevacizumab for HCC in the real world. Liver international : official journal of the International Association for the Study of the Liver 42 (4) (2022)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: how does underlying liver disease influence therapeutic strategy and outcomes ? Liver international : official journal of the International Association for the Study of the Liver (2022)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver (2022)
Erwan Vo Quang, Yusuke Shimakawa, Pierre Nahon
Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination. Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2021)
Laure Elkrief, Marie Lazareth, Sylvie Chevret, Valérie Paradis, Marta Magaz, Lorraine Blaise, Laura Rubbia-Brandt, Lucile Moga, François Durand, Audrey Payancé, Aurélie Plessier, Cendrine Chaffaut, Dominique Valla, Marion Malphettes, Alba Diaz, Jean-Charles Nault, Pierre Nahon, Etienne Audureau, Vlad Ratziu, Laurent Castera, Joan Carles García-Pagán, Nathalie Ganne-Carrie, Pierre-Emmanuel Rautou, null null
Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. Hepatology (Baltimore, Md.) 74 (1) (2021)
Thi Thu Nga Nguyen, Agnès Rode, Hervé Trillaud, Christophe Aubé, Anne Frédérique Manichon, Arnaud Hocquelet, Anita Paisant, Thong Dao, Pierre Nahon, Nathalie Ganne-Carrié, Lorraine Blaise, François Cauchy, Olivier Sutter, Olivier Séror, Jean Charles Nault
Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2021)
Pierre Nahon, Eric Vibert, Jean Charles Nault, Nathalie Ganne-Carrié, Marianne Ziol, Olivier Seror
Optimizing curative management of hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver (2021)
Víctor Sapena, Marco Enea, Ferràn Torres, Ciro Celsa, Jose Ríos, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Mariño, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, Stefano Brillanti, Fabio Conti, Elisabetta Degasperi, Ming-Lung Yu, Pei-Chien Tsai, Kévin Jean, Mohamed El Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G Singal, Caitlin C Murphy, Mohamed Ahmed Samy Kohla, Chiara Masetti, Jean-François Dufour, Nicolás Merchante, Luisa Cavalletto, Liliana Lc Chemello, Stanislas Pol, Javier Crespo, Jose Luis Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Cammà, Jordi Bruix, Giuseppe Cabibbo, Maria Reig
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut (2021)
Moana Gelu-Simeon, Maïté Lewin, Maria Ostos, Tatiana Bayan, Maria Beso Delgado, Elina Teicher, Richard Layese, Françoise Roudot-Thoraval, Hélène Fontaine, Rodolphe Sobesky, Dominique Salmon-Céron, Didier Samuel, Olivier Seror, Pierre Nahon, Laurence Meyer, Jean-Charles Duclos-Vallée, null null
Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Liver international : official journal of the International Association for the Study of the Liver 39 (1) (2018)
Pierre Nahon, Jean-Charles Nault
Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 37 (11) (2017)
S Pol, G Haour, Hélène Fontaine, C Dorival, V Petrov-Sanchez, M Bourliere, J Capeau, P Carrieri, D Larrey, C Larsen, P Marcellin, J-M Pawlostky, Pierre Nahon, F Zoulim, Patrice Cacoub, V de Ledinghen, P Mathurin, F Negro, G-P Pageaux, Y Yazdanpanah, L Wittkop, J-P Zarski, F Carrat, null null
The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Alimentary pharmacology & therapeutics 46 (11-12) (2017)
Pierre Nahon, Olivier Seror, Isabelle Durand-Zaleski
Reply. Hepatology (Baltimore, Md.) 66 (1) (2017)